# Ibuprofen (MOMENT ACT ANALGESIC Granules) Pharmacokinetic Study

> **NCT02482155** · PHASE1 · COMPLETED · sponsor: **Aziende Chimiche Riunite Angelini Francesco S.p.A** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT02482155
- **Lead sponsor:** Aziende Chimiche Riunite Angelini Francesco S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02482155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02482155, "Ibuprofen (MOMENT ACT ANALGESIC Granules) Pharmacokinetic Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02482155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*